3 Stocks I Saw on T...
Valeant Pharmaceuticals International Inc (VRX: NYSE)
$48.04 1.39 | 2.98%
05/24/12 - 04:06 PM ET
1.91M / 1.78M
Vol / Avg. Vol:46.93 / 46.65
Open / Prev. Close:46.55 - 48.37
Today's Range:32.05 - 59.94
52 Wk Range:2.91%
Performance YTD:TheStreet Rating:
Portfolios with VRX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ProLee Ainslie - Maverick Capital
- ProRuane Cunniff
- UserRetirement stocks
- ProPrivate Capital Management
- ProViking Global Investors
- UserWatch
- ContributorStocks With Big Insider Buy...
- Contributor12 Top Health Care Picks fo...
- ContributorStocks With Big Insider Buy...
Latest VRX Headlines from TheStreet
- Insiders Trading VRX, V, SONS, ANGI 05.22.12 | 10:05 am
- Insiders Trading VRX, RAX, GHDX 05.17.12 | 08:05 am
- 5 Stocks That Insiders Love Right Now 05.16.12 | 12:05 pm
- TheStreet Ratings Top 10 Rating Changes 05.07.12 | 01:05 pm
- Valeant Pharmaceuticals International Inc Stock Downgraded (VRX) 05.07.12 | 05:05 am
- Activist Shorts Austerity, Goes Long M&A 05.03.12 | 01:05 pm
- Valeant Pharmaceuticals International Stock Hits New 52-Week High (VRX) 05.03.12 | 09:05 am
- CVS, Flir Systems Set To Shine
04.13.12 | 05:04 am - Drug Maker Could be Ready to Roll
04.11.12 | 06:04 am - Upgrades Roundup: PRI, CYOU, GA, VCO, BID, SPIL, SSNC, TM, VRX, JNJ 04.09.12 | 06:04 am
Press Releases for VRX
- Valeant Pharmaceuticals Agrees To Acquire Certain Assets From Swiss Herbal - PR Newswire 05.24.12 | 07:05 am
- Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical - PR Newswire 05.03.12 | 08:05 am
- Valeant Pharmaceuticals To Announce 2012 First Quarter Results On May 3, 2012 - PR Newswire 04.16.12 | 05:04 pm
- Valeant Pharmaceuticals To Acquire Pedinol - PR Newswire 04.12.12 | 08:04 am
- Dr. LeWinn By Kinerase® Earns Four Good Housekeeping Seals - PR Newswire 04.03.12 | 10:04 am
- Valeant To Move Its Global Head Office To Quebec And Establish A New Center Of Excellence In Dermatology - PR Newswire 04.03.12 | 09:04 am
- Valeant Pharmaceuticals Agrees To Acquire Natur Produkt In Russia - PR Newswire 03.26.12 | 09:03 am
- Valeant Pharmaceuticals Agrees To Acquire Certain Assets From Gerot Lannach - PR Newswire 03.13.12 | 08:03 am
- Valeant Pharmaceuticals Acquires A 19.9% Minority Equity Investment In Biotech Company In Brazil - PR Newswire 03.12.12 | 08:03 am
- Kinerase® Announces Second Annual "Change Your Skin, Change Your Life" Charity Campaign - PR Newswire 02.22.12 | 10:02 am
Partner Headlines for VRX
- Valeant Pharmaceuticals - Aggressive Growth - Zacks 05.23.12 | 01:05 am
- Valeant Pharmaceuticals - Aggressive Growth - Zacks 05.23.12 | 01:05 am
- Weekly Top Insider Buys: IBM, BAC, SPG, HES, VRX - GuruFocus 05.21.12 | 01:05 pm
- Finance, Consumer, Tech Sectors Dominate Spotlight - Investor's Business Daily 04.27.12 | 04:04 pm
- Valeant in Expansion Mode - Analyst Blog - Zacks 04.13.12 | 04:04 pm
- Valeant Adds Russian OTC Drug Firm To Its Trophy Case - Investor's Business Daily 04.10.12 | 06:04 pm
- Valeant To Start Fifth Week Of Possible Flat Base - Investor's Business Daily 04.05.12 | 02:04 pm
- Last Week's (March 12-16) Notable Insider Purchases - Seeking Alpha 03.19.12 | 08:03 am
- Valeant: Well Managed For A Promising Future - Seeking Alpha 03.13.12 | 08:03 am
- UPDATE: Valeant Pharmaceuticals Posts Upbeat Q4 Profit - Benzinga 02.27.12 | 09:02 am





